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1 Glossary 
 
ACAT 
The Aged Care Assessment Team.  This is a multi-disciplinary team of workers who undertake 
assessments of people before authorising eligibility for subsidised packaged in-home care, residential 
respite in a Residential Aged Care Facility and permanent residential care. 
 
Advance Health Directive  
A document prepared by a person, when they have capacity, identifying their wishes with respect to 
future health care. 
 
CALD 
Culturally and Linguistically Diverse.  People who identify as having a specific cultural or linguistic 
identity in relation to their place of birth, ancestry, ethnic origin, religion, preferred language, or 
language(s) spoken at home (1).  
 
Carers 
Carers in this document refers to partners, family members and friends who provide support to the 
person who has dementia.  They are not paid for this work but may be eligible for a Centrelink 
payment and/or allowance.  The primary carer refers to the carer who provides significant unpaid 
support so that the person can or has been able to remain living in the community for as long as is 
reasonably viable. 
 
Care Worker 
This term describes workers who work with the person who has dementia and their carer in a very 
direct way.  They may undertake domestic chores or provide social support, respite or personal care.  
These workers are sometimes referred to as “support workers” or “personal care workers”.  They 
generally have a vocational qualification. 
 
Continuity of care 
This refers to the consistency of the care system which gradually introduces support from a low level 
of community based care to periods of overnight and ultimately residential respite and placement with 
minimal disruption to the person who has dementia and their carer. 
 
Continuum of care 
Refers to the range of services available from minimal in home support such as home cleaning to 
centre based day care, packaged care including Extended Aged Care at Home and cottage respite 
and residential care. 
 
Dementia Outcomes Measurement Suite Project 
This project of the Centre for Health Service Development at the University of Wollongong developed 
recommendations about a set of measures for use in the routine screening, assessment, diagnosis 
and outcomes monitoring of dementia conditions, and treatment evaluations in the health care 
framework in Australia. 
 
Enduring Power of Attorney 
This is a formal agreement that specifies the types of decisions that a nominated person will make on 
behalf of the person with dementia when they are no longer able to do so themselves.  
 
Evidence-based guidelines  
Guidelines emerging from the incorporation of pertinent scientific information gathered from the best 
available research. 
 
Family  
Family incorporates all individuals who are close to the person who has dementia including partners 
and relatives. 
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Guardian 
This term refers to a person who is appointed to make decisions of a personal nature for an adult who 
has impaired capacity. 
 
Health Professional  
Workers from the health and community care sectors such as nurses, doctors, social workers, case 
managers, and other qualified allied health workers. 
 
Informant based 
Information that is obtained from an informed observer e.g. a relative, partner, or close friend. 
 
Level of evidence  
A reflection of the recognised quality of research design, including the minimisation of bias.  The level 
hierarchy identifies the weight to be objectively assigned to the various research reported. 
 
Palliative approach 
A focus on comfort and care of an individual and their family who are dealing with a life-limiting illness.  
This positive approach focuses on comfort, care and the reduction of symptoms and distress. 
 
Proxy  
A person who speaks or reports for the person who has dementia. 
 
RACF  
Residential Aged Care Facility  
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2 Services and Resources 
 
Service 
 
Relevant Website Address 
 
 
Phone Number 
 
Access Economics: 
Dementia Estimates 
and Projections 
http://www.accesseconomics.com.au/publicationsreports/sh
owreport.php?id=17&searchfor=2005&searchby=year  
 
Alzheimer’s Australia www.alzheimers.org.au  
 
Freecall 
1800 100 500* 
Alzheimer’s 
Association of Qld 
www.alzheimersonline.org  1800 639 331* 
Austroads www.austroads.com.au   
Carer’s Qld www.carersqld.asn.au  
 
Freecall 
1800 242 636* 
Caresearch www.caresearch.com.au   
Centrelink www.centrelink.gov.au   
 
13 27 17 
Commonwealth 
Respite and Carelink 
Centres 
 
http://www.commcarelink.health.gov.au/  
For emergency respite support outside standard business 
hours, call 1800 059 059* 
Freecall 
1800 052 222* 
(business hours) 
Carers Australia and 
the Network of Carer 
Associations in each 
State and Territory: 
National Carer 
Counselling Program 
http://www.carersaustralia.com.au  1800 242 636 
Dementia Behaviour 
Management Advisory 
Services 
(DBMAS) 
http://www.health.gov.au/internet/main/publishing.nsf/Conte
nt/ageing-agdos-07-08.htm~ageing-agdos-07-08-
2.htm~ageing-agdos-07-08-2-3.htm  
Freecall 
1800 699 799* 
Elder Abuse 
Prevention Unit 
www.eapu.com.au  1300 651 192 
National Dementia 
Helpline 
http://www.alzheimers.org.au/content.cfm?infopageid=348&
CFID=697399&CFTOKEN=38268327  
Freecall 
1800 100 500* 
Palliative Care 
Australia 
www.palliativecare.org.au   
Palliative Care 
Information Service 
www.pcis.org.au  
 
Freecall 
1800 772 222* 
The Queensland 
Department of Justice: 
Office of the Adult 
Guardian 
http://www.justice.qld.gov.au/91.htm  
 
07 3234 0870 or 
1300 653 187 
(local call outside 
Brisbane) 
 
Royal Australian 
College of General 
Practitioners 
www.racgp.org.au   
* (calls from mobile phones charged at applicable rates) 
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3 On-Line Assessment and Measurement Tools 
 
Assessment/Measurement Tool 
 
Web Addresses 
Barthel Index www.strokecenter.org/trials/scales/barthel.pdf  
Clinical Dementia Rating (CDR)  www.alzheimer.wustl.edu/cdr/default.htm  
 
Cornell Scale for Depression in Dementia 
(CSDD) 
www.health.gov.au/internet/main/publishing.nsf/Cont
ent/2EED125A69192179CA2571AB0012C7D2/$File/
08dementia.pdf  
Dementia Outcomes Measurement Suite 
Project 
http://dementia.uow.edu.au/pdfs/2008resources/eadt
sc-jsansoni-domfindings-aug08.pdf  
Functional Activities Questionnaire (FAQ)  www.hospitalmedicine.org/geriresource/toolbox/the_f
unctional_activities.htm  
General Practitioner Assessment of 
Cognition (GPCOG) 
http://www.health.nsw.gov.au/pubs/2003/pdf/care_de
mentia_guide_67-71.pdf  
Geriatric Depression Scale (GDS)  www.stanford.edu/~yesavage/GDS.html  
 
Informant Questionnaire on Cognitive 
Decline in the Elderly (IQCODE) 
www.cmhr.anu.edu.au/ageing/Iqcode/index.php?p=1  
Kimberley Indigenous Cognitive Assessment 
tool (KICA-Cog) 
http://www.wacha.org.au/kica.html  
Neuropsychiatric Inventory Questionnaire 
(NPI-Q) 
http://www.health.nsw.gov.au/pubs/2003/pdf/care_de
mentia_guide.pdf  
Rowland Universal Dementia Assessment 
Scale (RUDAS) 
www.health.qld.gov.au/northside/html/rudas.asp  
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4 Introduction 
 
The word dementia refers to symptoms of a range of diseases which impact on the brain, are 
progressive and reduce cognitive and ultimately physical abilities.  Dementia is chronic in nature and 
affects each person and their carers and family members differently.  It impacts negatively on the 
person’s social and language skills, ability to learn and capacity to remember, and has implications for 
their mortality and quality of life.  Although it predominantly impacts on older people, dementia can 
affect younger people and is not a typical aspect of ageing.  Dementia requires intervention for its 
management.   
 
Alzheimer’s disease is the most common type of dementia, and accounts for more than 50% of 
dementia presentations.  Other well known forms of dementia include: Vascular dementia, Frontal 
Lobe dementia, Pick’s Disease, Lewy Body Disease and alcohol related dementia (2) .  Some people 
experience more than one of the dementia types and there is a diversity of additional forms of less 
common dementias. 
 
Access Economics estimated in 2005 that there would be more than 200,000 people with dementia in 
Australia and that by 2050 this will exceed 730,000 or 2.8% of the population (3).  Each state and 
territory differs in the proportion of people living with dementia primarily due to patterns of 
demographic change.  The most rapid growth states for dementia prevalence are Queensland, 
Northern Territory and Western Australia.  For current information on dementia refer to the Alzheimer’s 
Australia website (www.alzheimers.org.au ).  
 
Demand for access to high-quality dementia care for people living in the community will rise 
exponentially over the coming decade.  The National Framework for Action on Dementia identifies the 
importance of care across the trajectory of the illness and across all health care settings (4).   
 
The principles that underlie the National Framework for Action on Dementia and inform the 
development of these Guidelines and Pathways are (4): 
 
• People with dementia are valued and respected. Their right to dignity and quality of life is 
supported 
• Carers and families are valued and supported and their efforts are recognised and 
encouraged 
• People with dementia, their carers and families are central to making choices about care 
• Service responses recognise people’s individual journey 
• All people with dementia, their carers and families receive appropriate services that respond 
to their social, cultural or economic background or location 
• A well-trained supported workforce delivers quality care 
• Communities play an important role in the quality of life of people with dementia, their carers 
and families 
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These Clinical Practice Guidelines (Guidelines) and Care Pathways (Pathways), as part of the 
Cognition/Dementia Care System, promote the adoption of these principles in practice and also 
incorporate the following: 
 
 
In contemporary practice, clinicians increasingly work with models of care which define how care is 
delivered to specified target client groups.  The use of clinical guidelines specific to client groups is 
gaining popularity in Australia and other developed countries. While such guidelines are designed to 
improve both quality of care and health outcomes, difficulties can arise when they are not based on 
contemporary scientific evidence.  In recognition of the importance of guidelines based on the 
systematic identification and synthesis of best available current evidence the National Health and 
Medical Research Council (NHMRC) has produced a guide to the development, implementation and 
evaluation of clinical practice guidelines (5).  
 
The Guidelines and Pathways have been developed using the principles suggested by the NHMRC 
(5).That is, guidelines should be:
1. Focused on outcomes 
2. Based on the best available evidence 
3. A synthesis of the best available evidence 
4. Overseen by a multidisciplinary team including consumers 
5. Flexible and adaptable to local conditions 
6. Developed cognisant of  resource constraints 
7. Disseminated and implemented to target audiences 
8. Evaluated 
9. Revised regularly 
• Dementia prevention and early intervention play an important role in healthy ageing 
• Equitable access to dementia related information, support and services should be 
available to people with dementia, their carers and family members, including those in 
special circumstances such as people of different cultural backgrounds, sexual 
orientation and those living in rural and remote areas 
• Coordination and flexibility of care is vital for people with dementia, their families and 
carers 
• Consultation and collaboration with people who have dementia, their carers, Health 
professionals and advocates is essential to developing and delivering good dementia 
care 
• A whole-of-community approach promotes optimum support and outcomes for people 
living with dementia, their families and carers 
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4.1 Scope of The Guidelines 
 
The Guidelines and Pathways encompass non–pharmacological care for the person with dementia 
from recognition, assessment and diagnosis until death.  These Guidelines and Pathways are 
intended to be used by health professionals and policy makers who plan, organise and deliver care for 
people who have dementia and their carers. 
 
The Guidelines and Pathways reflect a contemporary evidence base but are not intended for use in 
every circumstance involving people with dementia.  While it is acknowledged that Indigenous 
Australians generally experience considerable health disadvantage, it is not suggested that 
implementing these Guidelines and Pathways with this special needs group would be an evidence 
based response.  This is an area of evidence gap.  However, where appropriate information or 
evidence based tools are available for this client group, they have been included in the Guidelines and 
Pathways. 
 
The Guidelines and Pathways have been developed as a resource which promotes effective and 
coherent support for people with dementia across general practice and community based care 
settings. 
 
The journey of dementia usually spans a number of years and care may be provided from a range of 
health professionals across various settings. These Guidelines and Pathways are presented in three 
phases to reflect the challenges faced by people with dementia and their caregivers as their parallel 
journeys unfold.  Each phase includes evidence based Guidelines, Practice Tips and Pathways for 
care workers, allied health professionals and General Practitioners (GPs).  The identified phases are: 
1. Recognition, Assessment and Diagnosis Phase 
2. Post Diagnosis, Monitoring, Management and Care Phase 
3. The Advanced Phase 
 
The collaborative approach to support promoted in each of the phases is intended to reflect currently 
available evidence and to offer tools which facilitate the delivery of an effective continuum of care for 
people who have dementia and their carers. 
 
For this reason practice tips, which demonstrate how a guideline might be acted upon have been 
included in the document.  These practice tips have been derived from experience, suggestions from 
focus groups or literature at an opinion of expert level. 
4.2 Development of the Guidelines 
 
The Clinical Practice Guidelines and Care Pathways for People with Dementia Living in the 
Community were developed under the direction of a multidisciplinary panel and in consultation with 
key stakeholders and consumers.  An initial process in the guideline development was the review and 
synthesis of existing guidelines.  Existing published guidelines were sourced from searching websites 
known to contain guidelines such as: 
 
 
Guidelines were reviewed to ascertain evidence base and appropriateness in the Australian context. 
This was undertaken using the Appraisal of Guidelines for Research and Evaluation Instrument (6) 
• National Institutes of Health (NIH) Clinical Trials Database 
• The National Research Register 
• National Institute of Clinical Excellence 
• National Guidelines Centre 
• Database of Abstracts and Reviews, Cochrane Library (DARE) 
• Google search engine – Dementia Clinical Guidelines 
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(AGREE) (see Appendix 1).  Guidelines that reached a rating of 70% were included. A total of twenty 
three guidelines pertinent to the care of people with dementia were reviewed.  Of these, fourteen were 
rated as suitable for inclusion (Appendix 2) and the remaining nine guidelines were excluded 
(Appendix 3).  From the guidelines which met the AGREE criteria, recommendations were extracted 
into an evidence matrix.  As different levels of evidence were used depending on the guideline’s 
authors, a rating based on the National Health and Medical Research Council (NHMRC) levels of 
evidence (7) was assigned by two members of the review team (Appendix 4).  This process was 
undertaken prior to April, 2006.  Some additional guidelines were released subsequent to that time, 
and, where appropriate, evidence from these has also been incorporated in these Guidelines and 
Pathways. In addition, where an instrument has been recommended through the Dementia Outcomes 
Measurement Suite (DOMS) Project (8) the expert opinion of the DOMS National Expert Panel 
members has been accepted as meeting international standards of evidence suitable for inclusion in 
guidelines.   
 
It is recommended that these Guidelines and Pathways be reviewed in three to five years. 
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5 Recognition, Assessment And Diagnosis Phase 
In the recognition, assessment and diagnosis phase of dementia care it is important for 
multidisciplinary health professionals to recognise early cognitive changes and undertake appropriate 
assessment and any indicated referrals.  An understanding by health professionals of the clinical and 
ethical issues related to early diagnosis and associated disclosure enables them to support the person 
with dementia and the carer appropriately during this time.  It is important to understand that both the 
person with dementia and the carer may experience feelings of grief and loss from the time of 
diagnosis (9). 
 
Specifically in this phase health professionals are responsible for: 
 
The onset of dementia is very gradual, and it is often not possible to identify when symptoms first 
presented.  Alzheimer’s Australia has identified some signs of early dementia that may serve as 
prompts to seek professional assessment (10).  The person may: 
• Appear more apathetic, with less sparkle 
• Lose interest in hobbies or activities 
• Be unwilling to try new things 
• Be unable to adapt to change 
• Show poor judgement and make poor decisions 
• Be slower to grasp complex ideas and take longer with routine jobs 
• Blame others for ‘stealing’ lost items 
• Become more self-centred and less concerned with others and their feelings 
• Become more forgetful of details of recent events 
• Be more likely to repeat themselves or lose the thread of their conversation 
• Be more irritable or upset if they fail at something 
• Have difficulty handling money 
• Diagnosis of dementia and where possible identification of the sub-type of dementia 
• Assessing the functional abilities of the person with dementia using validated tools 
• Assessing the cognitive function of the person with dementia using validated tools 
• Providing support and information for the person with dementia and their carer regarding the 
diagnosis of dementia 
• Assessing and planning treatment for any co-morbidities 
• Understanding the knowledge of the person with dementia and their carer with respect to the 
diagnosis of dementia and its implications 
• Identifying services required to meet the needs of the person with dementia and their carer 
• Assessing the understanding of advance care directives of the person with dementia and their 
carer 
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5.1 Definition of dementia 
 
Dementia describes a progressive decline in an individual’s cognition and functional ability.  It can be 
symptomatic of a number of diseases which attack the brain.  The International Classification of 
Disease (ICD-10) defines dementia as: 
 
A syndrome due to disease of the brain, usually of a chronic or progressive nature, in which 
there is disturbance of multiple higher cortical functions, including memory, thinking, orientation, 
comprehension, calculation, learning capacity, language, and judgement.  Consciousness is not 
clouded. Impairments of cognitive function are commonly accompanied, and occasionally 
preceded, by deterioration in emotional control, social behaviour, or motivation.  This syndrome 
occurs in Alzheimer's disease, in cerebrovascular disease, and in other conditions primarily or 
secondarily affecting the brain (11). 
5.2 Different types of dementia 
 
There are many different types of dementia and it is possible for someone to have more than one 
type, such as a combination of Alzheimer’s disease and Vascular dementia. The four most common 
types are Alzheimer’s Disease, Vascular Dementia, Dementia with Lewy Bodies and Fronto-temporal 
lobe dementia. There are a variety of other less common types including Cruetzfeld-Jacob disease, 
and dementias which are secondary to diseases such as Parkinson’s and Huntington’s disease.  It is 
important that international standardised criteria are  used in identifying the dementia subtype (12). 
 
Alzheimer’s Disease (AD) is the most frequently diagnosed type and accounts for between 50 and 
70% of all dementias. The average time a person has AD is eight years but this can vary from 3 to 20 
years.  AD has been classified into three stages, beginning with mild symptoms of memory loss and 
disorientation.  The middle stage is marked by further loss of function, particularly with activities of 
daily living, and in the final stage the person has communication difficulties and becomes completely 
dependent for all activities of daily living.  Death usually occurs from pneumonia or infection (2). 
 
Vascular Dementia (VaD) is the broad term for dementia which is related to the circulatory system. It 
may occur suddenly after an acute vascular event, such as a stroke, or sub-acutely.  VaD occurs over 
approximately 8 years, a similar time span as AD, however there may be long periods of relative 
cognitive stability prior to a stepwise decline in function (2).  There are five variants of VaD: 
1. Arteriosclerotic 
2. Acute onset 
3. Multi infarct 
4. Sub cortical or Binswanger’s disease 
5. Mixed cortical sub cortical 
 
Dementia with Lewy Bodies (DLB) accounts for approximately 10% of dementias and is 
accompanied by the presence of intra-neuronal bodies within the brain.  Some symptoms of this 
dementia are specifically associated with the subtype.  These include the experience of visual 
hallucinations; a Parkinson like tremor or stiffness and wide fluctuations of cognitive symptoms such 
as attentiveness.  An increased risk of falls is also present.  The duration of illness in DLB ranges from 
less than 1 year to 20 years with a mean span of 3.3 to 6 years (13).  
  
Fronto-Temporal Lobe Dementia (FTD) is the name given to dementia when there is degeneration in 
one or both of the frontal or temporal lobes of the brain.  FTD causes progressive decline over a 
number of years and usually begins between the ages of 40 and 65 years. It is marked by an early 
loss of adequate personal perceptions and consequently social appropriateness.  A type of FTD is 
Picks Disease, which presents in the 30-40 year age range, is evident in familial history and spans 10 
to 15 years.  It manifests largely in personality and behavioural changes (2). 
 
Mild Cognitive Impairment (MCI) may be experienced by some people who can not be described as 
having dementia.  The diagnostic criteria include a memory condition but otherwise normal general 
function and activities of daily living.  This group has increased risk of developing dementia and so 
require monitoring for deterioration in function and cognition (14). 
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Accurate diagnosis of the dementia type is important so that appropriate and comprehensive care can 
be provided (15).  In addition specific diagnosis may impact on the individual’s eligibility to access 
licensed trial drugs and, in the case of Dementia with Lewy bodies, will indicate that the use of 
antipsychotic medication and/or tricyclic antidepressants could lead to serious adverse reactions (13, 
16). 
 
Imaging can be used to detect some causes of dementia and aid in differential diagnosis.  Structural 
neuroimaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI) 
are useful diagnostic tools (12, 15) as are neuropsychologic batteries (2).  However, the use of 
functional neuroimaging procedures such as single photon emission controlled tomography (SPECT) 
and positron emission tomography (PET) are not recommended for routine screening (12).  
 
Guideline Evidence Reference 
A diagnosis of subtype dementia should be made by clinicians 
with expertise in differential diagnosis using international 
standardised criteria  
Level I (12) 
Health care professionals should be aware of the importance of 
diagnosing DLB to avoid the use of neuroleptic agents 
Level II (13, 16) 
Health professionals need to have knowledge of the most 
common presenting symptoms of the various subtypes of 
dementia including mixed dementia 
Level IV (15) 
Structural imaging (CT or MRI) can be used to establish the 
diagnosis of dementia and aid in differentiation of type  
Level III (12, 15) 
5.3 Detection 
 
Despite the increased incidence of dementia there is no evidence to support routine population 
screening for those aged over 65 years (14, 16, 17).  A range of brief screening tools which can be 
administered by non specialist staff are available, however it is recommended that staff become 
familiar with the tools, identify the appropriate circumstances of their use, and undertake training and 
practice as appropriate before using the tools with the client population (8).  Health professionals are 
encouraged to consider referring people who show signs of mild cognitive impairment (MCI) for 
assessment as more than 59% of people who present with MCI later develop dementia (14).   
 
Carers, as informed sources, are a good source of reported decline in a person’s cognitive function 
(14, 16).  If loss of cognitive function is suspected by a carer, the health professional should assist the 
carer to complete the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) (18) or 
the Kimberley Indigenous Cognitive Assessment (KICA) - Carer (19), a sub component of the KICA-
Cog (19), which may be more culturally appropriate  for specific indigenous Australians (8).  The KICA-
Cog (19) is recommended by the DOMS Project as a culturally appropriate method of assessing 
dementia in Indigenous peoples over the age of 45 years who are living in rural and remote areas of 
Australia (8).  A recent investigation into its validity for assessment in such populations in Far North 
Queensland and the Torres Strait found that it is both valid and acceptable to community members 
and health professionals (20). Further assessment of the tool is required prior to application of the 
KICA-Cog in the urban population group (8).  The shortened version, the KICA-Screen (19), consisting 
of ten subject cognition questions used in conjunction with an eight item informant questionnaire, the 
KICA-Carer (19), is recommended as a screening tool for use in Primary Care and General Practice to 
determine the presence of cognitive impairment in rural and remote Indigenous peoples.  Where there 
is a positive score on either the KICA-Screen or the KICA-Carer, it is recommended that the full KICA-
Cog be used for further assessment.  
 
Health professionals should be mindful that the cognition, health and burden of the caregiver may 
influence reporting, as may the caregiver’s desire to minimise issues which could be perceived as 
socially negative.  Alternatively carers may focus on extreme behaviours in preference to the usual 
behaviour of the person who may have dementia (8).  
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Guideline Evidence Reference 
When carers describe cognitive decline in a person, cognitive 
assessment and careful follow-up are indicated 
Level III (21) 
The Informant Questionnaire on Cognitive Decline in the Elderly 
(IQCODE) can be a useful adjunct to cognitive testing.  The 
IQCODE can be found at the following website: 
http://cmhr.anu.edu.au/ageing/Iqcode/index.php?p=1  
Level I (18) 
The KICA-Screen and KICA-Carer are suitable for Indigenous 
Australians who are aged over 45 and who live in rural and remote 
areas 
http://www.wacha.org.au/kica.html 
Level IV (8) 
5.4 Assessment and diagnosis 
 
A diagnosis of dementia should only be made after a comprehensive assessment.  An initial clinical 
assessment that combines multiple and varied sources of information is recommended to evaluate 
patients with suspected dementia.  This assessment should include a medical, family, social, cultural 
and medication history and detail of the chief complaint (17).  A comprehensive patient assessment 
using the Medicare item numbers 700 to 706 is recommended where the person is eligible (22).  
 
While most people with dementia can be assessed and managed adequately by their primary care 
physicians, a referral to a geriatrician, geriatric psychiatrist, neurologist or other professional may be 
necessary (21).  Indicators for referral may be an uncharacteristic presentation of subtype or symptom 
history, onset prior to age 60, lack of clarity about the diagnosis, the presence of violent or suicidal 
behaviours, agitation or persistent depression.  Neurological referral is important when Parkinson-like 
features, focal neurological signs or atypical neuro-imaging observations occur.  Family members may 
also benefit from referral to a clinical psychologist for psychotherapy and social workers can assist 
with counselling and linking to community resources (23).   
 
5.5 Cognitive Assessment 
 
Cognitive assessment for those suspected of having dementia needs to include examination of 
attention and concentration, orientation, short and long term memory, praxis, language and executive 
function (17).  The assessment of the patient’s cognitive abilities is considered the optimum method to 
determine the existence of dementia.  Formal cognitive testing needs to be undertaken using 
standardised instruments.  Factors such as visual impairment, sensory impairment and physical 
disability need to be assessed and considered in selecting the mental status tests to be implemented.  
(17, 24).  Other aspects, particularly in the Australian context are language and cultural 
appropriateness (8).  Instruments recommended for cognitive assessment include: 
 
• The MMSE was identified (16, 17, 21, 25, 26) but there may be copyright and accessibility 
issues with respect to its use and the MMSE-3MS (27) which is a reliable and validated tool is 
a recommended alternative 
• The General Practitioner Assessment of Cognition (GPCOG) (17, 28) is recommended for 
initial screening by General Practitioners   
• The Global Deterioration Scale (GDS) (29)  is recommended for all stages from initial 
assessment (8) 
• The Clinical Dementia Rating (CDR) (30) 
• The KICA-Cog for Indigenous Australians who are aged over 45 years and from rural and 
remote areas (8). 
 
The Rowland Universal Dementia Assessment Scale (RUDAS) (31) has recently been developed in 
Australia and is suitable across most cultures. While limited testing of this scale has been undertaken 
early indications are that the tool is valid and reliable.  It is recommended as a short cognitive 
screening tool for the assessment of dementia in multicultural population groups by primary health 
care workers. The DOMS Project reports that the RUDAS items are easily translated to other 
languages (8).   
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For remote Indigenous Australians who are aged over 45 years and live in rural and remote locations 
the Kimberley Indigenous Cognitive Assessment tool, KICA-Cog (19), is recommended if there has 
been a positive score on either the KICA-Screen or the KICA-Carer.  Further assessment of the tool is 
required prior to application of the KICA-Cog in the urban population group.    
 
Guideline Evidence Reference 
The MMSE-3MS is recommended for cognitive testing   Level IV (8) 
The GDS is recommended for all stages from initial assessment 
http://www.stanford.edu/~yesavage/GDS.html  
Level IV (8) 
The Rowland Universal Dementia Assessment Scale (RUDAS) is 
suitable across cultures.  A copy of the RUDAS can be found at the 
following website: www.health.qld.gov.au/northside/html/rudas.asp  
Level III (32) 
The full KICA-Cog is recommended for use where there is a positive 
KICA-Screen or KICA-Carer score.  A copy of the KICA-Cog and its 
components can be found at the following website:  
http://www.wacha.org.au/kica.html 
Level IV (8) 
The General Practitioner Assessment of Cognition (GPCOG) is 
recommended for cognitive screening.  A copy of the GPCOG is 
available in the Care of Dementia Patients in General Practice 
Guidelines and can be found at the following website: 
http://www.health.nsw.gov.au/pubs/2003/pdf/care_dementia_guide_67-
71.pdf 
Level IV (8) 
 
Referral to a geriatrician, geriatric psychiatrist, neurologist or other 
professional may be necessary for assessment and management 
Level IV (21, 33) 
The Clinical Dementia Rating (CDR) can be used for all stages from 
initial assessment.  It is suggested that it may be more appropriate for 
use by specialists and researchers. Information on this scale can be 
found at the following website:  
www.alzheimer.wustl.edu/cdr/default.htm  
Level IV (8)  
 
Practice Tip 
An interpreter may be required for people who are hearing impaired or of a CALD background 
 
5.6 Investigations for co-morbidities 
 
Investigations to support cognitive testing in the diagnosis of dementia should include routine 
haematology and biochemistry.  As Vitamin B12 deficiency and hypothyroidism is common in older 
people tests for these issues should also be included but there is no evidence to support routine 
testing for syphilis (12, 17, 21).  Other investigations will depend on clinical presentation.  
 
Guideline Evidence Reference 
Laboratory tests that may be helpful in a dementia screen are: 
complete blood count; measurement of thyroid stimulating 
hormone; serum electrolytes; serum calcium; serum B12; folate 
and serum glucose 
Level IV (33,17) 
It is critical to treat general medical conditions identified at 
assessment 
Level I (17, 33) 
5.7 Functional assessment 
 
A home visit is useful to obtain a history and to assess the safety and quality of the environment in 
which the person lives (22), including risk of falls.  Functional assessment needs to include 
determination of ability/disability. The Functional Activities Questionnaire (FAQ) (34) is useful for 
assessing instrumental activities of daily living and functional impairment.  The Barthel Index (35)  is a 
generic measure of Activities of Daily Living (ADL) suitable for community based use (8) .  Also 
recommended for use in community based settings are the Alzheimer’s Disease Cooperative Study-
ADL (36) and the Disability Assessment for Dementia (37). These rely on proxy reporting.  The 
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Cleveland Scale-ADL (38) is suitable for use in acute and residential care settings and relies on 
observation (8). 
 
 
5.8 Differential diagnosis 
 
Clinical deficiencies that lead to cognitive impairment require treatment.  These may include: thyroid 
therapy, Vitamin B12 replacement or treatment for alcohol dependence (21).  In addition, the General 
Practitioner should exclude licit or recreational drugs as possibly impacting on a person’s cognitive 
impairment (22). 
 
The Neuropsychiatric Inventory Questionnaire, short format (NPI-Q) (39) may be useful in assessing 
neuropsychiatric symptoms including apathy depression, psychosis and agitation as well as related 
carer concerns (24, 39).  The scale can assist in identifying different causes of dementia and the 
includes symptoms which are often associated with fronto-temporal dementias.  It can also be helpful 
in assessing the level of caregiver distress (39). 
 
Health professionals should be aware that dementia, delirium and depression have overlapping 
clinical features and may co-exist.  A structured assessment to distinguish between these conditions 
should be used (26). The Confusion Assessment Method (CAM) (40) and Delirium Rating Scale – 
Revised 98 (DRS-R98) (41) are validated methods that distinguish delirium and dementia.  However 
the CAM is not a suitable tool for repeat measurement as it does not indicate the severity of the 
delirium.  The DRS-R98 is more comprehensive and can be useful when repeat measurement is 
necessary although it requires a 24 hour observation period and may not be applicable to all 
community settings. Depression can be assessed in less severe cases and in community settings 
using reliable and valid self report scales such as the Geriatric Depression Scale (GDS) (42), or 
informant reports using the Cornell Scale for Depression in Dementia (CSDD) (43) which can be 
completed by a clinical informant.  Nurses and allied health workers who know the older person well 
can also use the Hayes and Lohse non-Verbal Depression Scale which is a valid and reliable measure 
of depression (44). 
 
Guideline Evidence Reference
An assessment of the home environment should be conducted  Level IV (22) 
The Functional Activities Questionnaire (FAQ) is useful for assessing 
instrumental activities of daily living and functional impairment. The FAQ  
can be found at the following website: 
www.hospitalmedicine.org/geriresource/toolbox/the_functional_activities.htm 
Level III 
 
(34) 
The Barthel Index (though generic) is a suitable tool for measuring Activities 
of Daily living (ADL) in the community setting. The Barthel Index  can be 
found at the following website:  
www.strokecenter.org/trials/scales/barthel.pdf  
Level IV (8) 
The Alzheimer’s Disease Cooperative Study – ADL and the Disability 
Assessment for Dementia are appropriate tools (though proxy) for 
community based measurement 
Level IV (8) 
The Cleveland Scale-ADL is suitable for acute and residential care settings Level IV (8) 
Guideline  Evidence Reference 
The Neuropsychiatric Inventory Questionnaire (NPI-Q) can be 
useful to assess neuropsychiatric symptoms and the impact 
this has on the caregiver.  It assists in identifying different 
causes of the dementia.  A copy of the NPIQ is available in 
the Care of Dementia Patients in General Practice Guidelines 
and can be found at the following website:  
http://www.health.nsw.gov.au/pubs/2003/pdf/care_dementia_
guide.pdf  
Level II 
 
 
 
 
(24, 39) 
It is critical to identify and treat general medical conditions 
discovered at assessment 
Level I (45) 
The Confusion Assessment Method (CAM) is a validated tool Level IV (8) 
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5.9 Informing the patient and carer 
 
A diagnosis of dementia carries with it an ethical burden for the practitioner with respect to disclosure 
and support.  There is a consensus among health professionals that favours disclosure of diagnosis; 
however health professionals should be aware that some people with dementia and/or their carers 
may not wish to know their diagnosis.  This may be particularly pertinent in relation to Indigenous 
people and people who are from CALD backgrounds.  For these groups it may be culturally  
insensitive or inappropriate to disclose a diagnosis.  When disclosure does not occur, the reasons for 
this decision should be clearly documented (21). 
 
Knowledge about the diagnoses can assist the person with dementia and their family members to 
make informed decisions about further investigations and treatment.  It can also alert them to the need 
for future planning, making lifestyle changes (e.g., planning for losing the ability to drive or acceptance 
of community based services), addressing financial and legal issues and preparing health directives.  
It can give family members the opportunity to identify that a caring role may be necessary if the person 
with dementia is to remain living in the community. 
 
Following a diagnosis of dementia, clinicians should give adequate time and an appropriate 
opportunity to discuss the diagnosis and its implications with both the person with dementia and family 
members.  People with dementia and their families require ongoing support to cope with the diagnosis 
(15, 17, 21) and the associated health, lifestyle, financial and legal implications.  Both the person with 
dementia and their carer may also be experiencing grief and loss (46).  A referral from the health 
professional to Alzheimer’s Australia is recommended (Appendix 5). 
 
In early dementia the person usually has the capacity to identify a surrogate decision maker (24). 
Legal matters and decisions need to be addressed soon after diagnosis while the person who has 
dementia is still able to make and communicate these decisions (22). 
 
 
 
 
 
 
 
to assist in distinguishing delirium and dementia but does not 
indicate severity. The CAM can be found at the following 
website: 
www.consultgerirn.org/uploads/File/Confusion%20Assessme
nt%20Method%20(CAM).pdf  
The Delirium Rating Scale Revised 98 (DRS- R98) is also a 
validated tool for distinguishing between delirium and 
dementia.  It is more comprehensive than the CAM and can 
be repeated to measure changes.  It requires a 24 hours 
observation period and may not be suitable across all 
community settings 
Level IV (8) 
The Geriatric Depression Scale (GDS) is a valid self report 
scale. The GDS can be found at the following website: 
www.stanford.edu/~yesavage/GDS.html  
Level IV (8) 
An Clinical Informant tool suitable for use is the Cornell Scale 
for Depression in Dementia (CSDD) and it  can be found at 
the following website:  
www.health.gov.au/internet/main/publishing.nsf/Content/agein
g-rescare-natframe.htm~ageing-rescare-natframe08.htm  
Level IV (8) 
Depression can be measured by staff who know the older 
person well with the Hayes and Lohse Non-Verbal 
Depression Scale 
Level IV (8) 
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Guideline Evidence Reference 
Health professionals need to inform the family of the diagnosis 
of dementia 
Level IV (21) 
Practitioners need to provide the person and their family with 
written information about: signs and symptoms of dementia, the 
anticipated course and prognosis, treatments, local care and 
support services, support groups, financial, legal and advocacy 
advice, and voluntary organisations. Any advice given needs to 
be clearly documented in the person’s notes  
Level IV (21) 
 
Practice Tips 
For some CALD groups it may be culturally insensitive/inappropriate to disclose a diagnosis 
In some families of a CALD background a key decision maker makes all the decisions surrounding 
the care of the person who has dementia and how other family members should respond.  It is 
important to identify this person so as to inform their decisions and to respond to the needs of all 
involved family members.  The primary carer may not have decision making authority within their 
family 
The DOMS identifies the languages in which the various measurement tools are available (8) 
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5.10 General Practitioner’s Recognition, Assessment and Diagnosis Phase Care Pathway  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Pathway continues - General Practitioner’s Post Diagnosis, Monitoring, Management and Care Phase Care Pathway 
No 
Unsure 
Refer to 
Geriatrician or 
other 
Specialist for 
confirmation  
of diagnosis 
and sub-type 
and advice 
concerning 
appropriate 
medications  
Yes 
If appropriate inform 
patient and carer of 
diagnosis and subtype 
of dementia 
 
Information should be 
given to the person and 
family and documented in 
the person’s notes. 
  
Provide information  
• Signs and symptoms 
of dementia 
• Course and prognosis 
of subtype 
• Treatments 
• Local care and support 
services, including 
transport.  
• Financial, legal and 
advocacy advice 
 
If appropriate, provide 
feedback to community 
services (A fax sheet for 
this purpose may have 
been provided with the 
service based needs 
assessment/ referral) 
 
Refer to Alzheimer’s 
Australia by faxing the 
Referral Form provided 
Cognitive Assessment (one of)  
MMSE-3Ms 
Rowland Universal Dementia Assessment Scale (RUDAS) 
General Practitioner Assessment of Cognition (GPCOG) 
Kimberley Indigenous Cognitive Assessment tool (KICA- 
Screen and KICA-Carer for Rural Indigenous) 
Neuropsychiatric Inventory Questionnaire (NPI-Q)  
 
Haematology, biochemistry investigations which include 
Thyroid stimulating hormone; serum electrolytes; serum 
calcium, serum B12, folate and serum glucose  
IADL Assessment (one of) 
The Functional Activities Questionnaire (FAQ) 
The Barthel Index   
Disability Assessment for Dementia 
Differential Diagnosis 
Assess for the presence of 
delirium using the Confusion Assessment Methods (CAM) 
depression using the Geriatric Depression Scale (GDS)  
 
Assess co-morbidities  
Classification of Subtype  
Structural imaging (CT or MRI) can be used to establish the 
diagnosis of dementia and aid in differentiation of type 
Patient and/or carer 
identify memory or 
personality changes or 
GP receives service 
linked referral with 
request for assessment. 
(consider eligibility for 
health assessment under 
items 700 to 706) 
Reassess in 6 – 12 mths 
No 
Advise referring service 
Yes CLASSIFICATION OF DEMENTIA TYPE  DIAGNOSIS OF DEMENTIA  
25 
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5.11  Health Professional’s Recognition, Assessment and Diagnosis Phase Care Pathway
Health professional asks the carer to complete 
The IQCode or KICA-screen or KICA-Carer (Indigenious) 
Health Professional scores the IQCode (or KICA-Carer or KICA screen) 
and if a score of > 3.3 (on IQ Code) or a positive score (on KICA-Carer 
KICA-Screen) then complete: MMSE-3Ms, RUDAS, or KICA-Cog 
Complete: Appropriate evidence based depression and delirium screening 
assessments: GDS, CAM, CSDD or the Hayes and Lohse non-Verbal 
Depression Scale 
Undertake home environment assessment 
Complete: Functional Assessment Questionnaire 
Complete: Carer Strain Index if appropriate 
Complete: NPIQ 
 
Health professional 
identifies cognitive decline, 
not related to reversible 
causes
Carer identifies memory or 
personality changes, not 
related to reversible causes 
COGNITIVE CHANGES INDICATED 
No Yes 
Health professional to reassess 
6 – 12 months 
 
Refer to General  
Practitioner for 
assessment and diagnosis 
(see GP Pathway) 
 
DIAGNOSIS OF 
DEMENTIA  
Yes 
CLASSIFICATION 
OF DEMENTIA TYPE  
No 
No 
Assessment of carer and person with 
Dementia  
 
Complete  
• Complete Service related needs inventory, 
including falls risk assessment 
 
                                                                               
Provide information on 
• Signs and symptoms of dementia  
• Course and prognosis of subtype 
• Treatments 
• Local care and support services 
• Financial, legal and advocacy advice 
• Transport services 
• Advance planning 
Yes 
Contact GP to follow up with Geriatrician’s subtype identification 
Formulate preliminary care plan with person 
who has dementia, carer, GP and other health 
services, including, care workers 
Pathway continues – Health professional’s Post Diagnosis, Monitoring, Management and Care Phase Care Pathway 
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5.12 Care Worker’s Recognition, Assessment and Diagnosis Phase Care Pathway
Care manager to review care plan and adjust 
accordingly. Care Coordinator to Reassess 6 
– 12 mths 
Care worker identifies a client may have cognitive decline, or 
changes in memory or personality  
Health professional/care manager refers to GP 
Care worker refers concerns to health professional/care manager who then completes assessments as per 
Health Professional Care Pathway for recognition, assessment and diagnosis of dementia 
Care worker assists the health professional/care manager to develop care plan and 
to review care plan 3 monthly and earlier if client’s condition changes   
 
Care worker then follows the care plan 
Pathway continues – Care Worker’s Post Diagnosis, Monitoring, Management and Care Phase Care Pathway 
DIAGNOSIS OF 
DEMENTIA  
AND SUBTYPE 
No Yes 
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6 Post Diagnosis, Monitoring, Management And Care Phase 
This period follows the early dementia and diagnosis phase.  At this time the person with dementia 
may be considerably more dependent due to reduced cognitive and functional capacity and a high 
level of in-home support may be required or residential placement may be approaching. 
 
Specifically in this phase health professionals are responsible for: 
 
Issues that may be of concern for the person with dementia are that they may (10):  
• Be forgetful of recent events and memory for the distant past seems better, but some details 
may be forgotten or confused 
• Be confused regarding time and place 
• Become lost if away from familiar surroundings 
• Forget names of family or friends, or confuse one family member with another 
• Forget saucepans and kettles on the stove.  
• May leave gas unlit 
• Wander around streets, perhaps at night, sometimes becoming lost 
• Behave inappropriately - for example, going outdoors in their nightwear 
• See or hear things that are not there 
• Become very repetitive 
• Be neglectful of hygiene or eating 
• Become angry, upset or distressed through frustration 
• Establishing goals aimed at maintaining independence, self care and safety, with the person 
who has dementia and their carer  
• Establishing procedures for regular review of care goals and developing new goals as required 
• Assessment and referral to other care providers as required 
• Establishing information sharing and communication between care providers  
• Providing effective communication strategies for the person with dementia, their carer and care 
providers 
• Assessing the carer’s knowledge and role in providing support for the person with dementia 
• Providing information and support to both the person with dementia and their carer 
• Assessing the psychosocial needs of the carer and resourcing them to meet these 
• Facilitating access to respite care as required 
• Providing appropriate interventions and review as required 
• Reviewing advance care directives 
• Supporting the carer in making decisions regarding alternative care arrangements when 
appropriate 
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6.1 Management Strategies for Persons with Dementia 
6.1.1 Treatment of co-morbidities  
People living with dementia have similar numbers of co morbidities to that of the general population 
(age and race and sex adjusted) but they may be more inclined to miss specialists’ appointments and 
be less compliant with treatment due to cognitive impairment (22).  It is crucial that medical conditions 
that may contribute to confusion continue to be identified and managed (45).  Common medical 
conditions in this population include diabetes, hypoxia, anaemia, postural hypotension, infections, 
pain, urinary or faecal retention (22).  There is also an increased risk for epilepsy (47).  Psychological 
morbidities such as depression, delirium and anxiety need to also be assessed and managed (22). 
 
Guideline Evidence Reference 
Co-morbid medical conditions need to be identified and managed Level I (45) 
6.1.2 Behavioural management  
Once the initial stage of assessment has been undertaken any behavioural issues of concern can be 
explored.  Many people who have dementia demonstrate Behavioural and Psychological Symptoms of 
Dementia (BPSD) (8).  They may exhibit behaviours which are of concern and this can significantly 
impact on the carer’s ability to cope.  It is therefore important that behavioural changes are 
comprehensively assessed and reviewed at regular intervals.  The Revised Memory and Behavior 
Problems Checklist (RMBPC) is a carer informant tool which is reliable and valid (48).  Use of this tool 
can provide information on observable aspects of dementia related behaviours and also includes 
components of: memory, depression, disruptive behaviours and the carer’s emotional response to 
each of the behaviours.  It can useful in the planning interventions and establishing goals for both the 
carer and the person who has dementia (48). Behavioural assessments include consideration of: 
physical health, presence of pain, side effects of medication, individual biography, psychosocial 
factors, physical environmental factors and a behavioural analysis conducted by a professional in 
conjunction with family and care workers (17). 
 
The short format NPI-Q (39) is a brief, reliable, informant-based tool appropriate for assessing 
neuropsychiatric symptoms and related carer concerns (22) although the tool may be difficult for non-
trained staff to administer (8).  Similarly, the Behavioural Pathology in Alzheimer’s Disease Rating 
Scale (BE-HAVE-AD) (49) tool may offer some time challenges in administration by non-specialist staff 
but may be an appropriate behaviour focused tool. 
 
In most situations the information gained from the NPI-Q (50) about behavioural issues is sufficient.  
However if further investigation is indicated the recommended tools for exploring specific behavioural 
symptoms are: the Rating Scale for Aggression in the Elderly (RAGE) (51), the Cohen Mansfield 
Agitation Inventory (CMAI) (52), The Pittsburgh Agitation Inventory (PAI) (53), the Rating Anxiety in 
Dementia (RAID) (54), and The Apathy Evaluation Scale (AES) (55). Pain may be a source of 
agitation for the person with dementia and should be investigated (24). 
 
Guideline Evidence Reference 
The Revised Memory and Behavior Problems Checklist (RMBPC) 
can provide information on behaviours and the carer’s emotional 
response to these 
http://stressandhealth.stanford.edu/measures/RMBPC.html  
Level III (48) 
The Neuropsychiatric Inventory Questionnaire NPIQ short format 
can be used to assess neuropsychiatric symptoms and caregiver 
distress 
Level II (24) 
The Behavioural Pathology in Alzheimer’s Disease Rating Scale 
(BEHAVE-AD) tool may also be useful though it may be difficult 
for non-specialist staff to use 
Level IV (8) 
If further investigation of Aggression is required the RAGE is 
recommended 
Level IV (8) 
If further exploration of Agitation is required the Cohen Mansfield 
Agitation Inventory or the Pittsburgh Agitation Inventory can be 
applied 
Level IV (8) 
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If additional information about Anxiety is required the Rating 
Anxiety in Dementia (RAID) is available  
Level IV (8) 
Apathy can be explored in more detail through the Apathy 
Evaluation Scale (AES) 
http://www.tbims.org/combi/aes/index.html  
Level IV (8) 
Comprehensive assessment of behavioural problems should be 
conducted and reviewed regularly  
Level IV (17) 
Pain may be a source of agitation for people with dementia Level I (24) 
 
Management of these symptoms may include pharmacological and non-pharmacological intervention. 
The pharmacological management of behavioural changes is beyond the remit of these Guidelines 
and Pathways.  NSW Health provides a discussion of the pharmacological management of 
behavioural problems (22) as well as relevant Cochrane systematic reviews (www.cochrane.org ). 
 
Non-pharmacological interventions may include a variety of activities, techniques or therapies.  The 
available evidence base for the efficacy of these therapies is limited although some studies have 
shown that these therapies make a positive difference to some people who have dementia.  For 
example, exercise training has been found to improve fitness, physical and cognitive function and 
behaviours (56), Behaviour Management has been shown to improve aggression and depression (57) 
and Music Therapy (58) has appeared to reduce behaviours of concern (59).  Reminiscence Therapy 
was shown to improve cognition in a number of studies (60), however, there is limited evidence to 
support planned walking, attention-focused programs, functional skills training, activity programs, 
multidisciplinary care, reality orientation and caregiver education to improve behaviour symptoms (25).  
These findings should be treated with caution and further investigations into these therapies are 
needed as many of the studies which have been undertaken have had some methodological 
limitations or have not included sufficient numbers to enable generalisations.  It is therefore difficult to 
identify what aspects of the therapies lead to apparent positive change in the person with dementia.  It 
may be that the individual attention, time or other environmental factors of the intervention or that the 
sensitivity of the deliverer makes a difference.  These Guidelines and Pathways do not suggest that 
delivery of these types of therapies cease but that practitioners respond to results of further scientific 
evidence, translating these into practice when appropriate. 
 
At present there is no conclusive evidence to support: 
   
• Bright light therapy (61) 
• Validation therapy (62) 
• Snoezelen (63) 
• Aromatherapy (64) 
• Massage and touch (65) 
• Cognitive training interventions or individualised cognitive rehabilitation for people with early 
stage AD or VaD (66) 
 
Where there is persistent depression, behaviours of concern, aggression or a failure to respond well to 
treatment specialist referral may be necessary (23). 
6.1.3 Maintenance of function  
Promotion and maintenance of physical function can greatly assist the carer at home and potentially 
delay institutionalisation.  Health care practitioners can assist the person with dementia and their carer 
to promote and maintain independence.  Care plans should seek to maximise independent activity, 
enhance function, adapt and develop skills and minimise the need for support.  Behaviour 
modification, scheduled toileting and prompted voiding can reduce urinary incontinence (17, 67). 
 
People with dementia are at greater risk of falls and this risk is linked to the functional capability of the 
person and not the severity of dementia.  A person who has had a fall is at increased risk of further 
falls.  Health professionals’ awareness of factors such as epilepsy (47) and other contributors to falls 
such as medication, wandering and reversible confusion helps to reduce this risk (22). 
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Practice Tips 
The Alzheimer's Australia website offers information about the physical environment which might be 
of assistance in preventing falls 
http://www.alzheimers.org.au/content.cfm?infopageid=604&CFID=697399&CFTOKEN=38268327  
Funded services may be able to assist through occupational therapy intervention and arranging 
home modifications 
Queensland Health website provides information about falls prevention 
www.health.qld.gov.au/stayonyourfeet/default.asp  
 
For individuals with dementia who hold a driver’s license there is increased risk of driving errors and 
accidents. As there are individual differences in how dementia progresses and impacts the person’s 
cognitive and functional ability it is recognised that a diagnosis of dementia does not automatically 
indicate that a person should immediately cease driving although it is recommended that plans relating 
to transport options and discussion about driving issues should occur earlier rather than later in the 
progression of dementia (68).  Slight impairment in memory, orientation, perception, judgment and 
problem solving can impact negatively on driving ability (69) as can any co-morbidities and/or drug 
treatment (22) .  The Association of Australian and New Zealand Road Transport and Traffic 
Authorities (Austroads) provides a brochure for assessing fitness to drive on the following website: 
www.austroads.com.au/aftd. 
 
Advice from General Practitioners and allied health professionals to the person about how the 
dementia (and any co-morbidities) can impact on their driving is important.  In most Australian states 
the person is required to report their condition to the licensing authority. It is suggested that regular 
health assessments incorporate assessment of the skills required for safe driving as well as a 
discussion of any indicators that driving is becoming unsafe.  Referral to a Geriatrician may be helpful 
in offering a second opinion about the appropriateness of continuing to drive (22). 
 
The Health Practitioner might suggest that the person undertake a driving assessment although the 
costs associated with this are borne by the person with dementia and a Medicare rebate is not 
generally available.  In addition, follow up testing would be required if the person were to continue 
driving as the dementia progresses.  If the person who has dementia continues to drive when it is 
believed such action puts public safety at risk, the General Practitioner and Allied Health worker can 
report this to the licensing authority which may then undertake a driving assessment (68).  With 
respect to assessing and reporting fitness to drive, the duty to maintain confidentiality is qualified in 
order to protect public safety.  (This exemption applies to General Practitioners, Optometrists, 
Physiotherapists and Psychologists). 
 
Guideline Evidence Reference 
Behaviour modification, scheduled toileting and prompted 
voiding can reduce urinary incontinence 
Level I (67) 
Health professionals need to assist the person with dementia 
and their carer to promote and maintain independence 
Level IV (17) 
Driving ability may be impaired and the person with dementia 
should be advised of how their condition may impact on their 
driving and of the need to report their diagnosis to the driving 
licensing authority and to their insurer.  Information about 
assessing fitness to drive can be found at the following 
website: 
www.austroads.com.au/aftd/  
Level IV (22) 
Whilst the person with dementia continues to drive the health 
professional should regularly assess the person’s fitness to 
drive.  If the person continues to drive against advice and there 
is concern about public safety then the matter may be reported 
to the licensing authority 
Level IV (22) 
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Practice Tip 
Assistance with transport may be available through funded services 
6.1.4 Legal issues/Decision making capacity 
It is important for health professionals to facilitate ongoing discussions regarding legal and decision 
making capacity of the person who has dementia.  The Queensland Department of Justice website 
states the following about decision making capacity: 
 
Under the Guardianship and Administration Act 2000 (the Act), an adult is deemed to have 
capacity if they are capable of understanding the nature and effect of the decisions they are 
making, can freely and voluntarily make those decisions and can communicate those decisions 
in some way.  It is important to note that all adults who are the subject of an application before 
the Tribunal are presumed to have capacity until the Tribunal deems otherwise (70). 
 
There are not specific scales to measure capacity but a number of factors need to be considered. 
Areas of concern are: legal and financial arrangements and health care and domestic arrangements. 
Advance Health Directives, guardianship and enduring power of attorney are issues that need to be 
discussed early after diagnosis (22).  
 
Guardianship involves looking after the day to day arrangements of the person who has impaired 
capacity and in Queensland a close family member can take on the role of guardian without any 
formal arrangements for this to occur.  The Guardianship and Administration Tribunal can appoint 
individuals as Guardians and can also intervene if the informal arrangements appear to be less than 
adequate for the person who has dementia.  
 
While a person has capacity they may appoint an Enduring Power of Attorney to look after financial 
and legal matters in anticipation of the dementia impairing their decision making capacity. 
 
An Advance Health Directive is a written document prepared by the person while they still have 
capacity, stating their wishes about any future medical treatment or interventions. 
 
 
Guideline Evidence Reference 
Decision making capacity needs to be assessed regularly.  
Factors to be considered are: Attention, Language 
(comprehension and speech), memory, awareness and 
judgement 
Level IV (22) 
 
Practice Tip 
Information about these legal matters can be obtained from the Qld Department of Justice website: 
http://www.justice.qld.gov.au/17.htm  
6.1.5 Service provision 
Multiple agencies provide care in the community for the person with dementia and their carer.  To 
ensure coordination of care between services it is important to have a clear description of the roles of 
all care managers and agencies involved in the delivery of care to people with dementia.  The carer 
and the person who has dementia need to be provided with advice on how agencies work together to 
provide a comprehensive service from diagnosis to the advanced phase (17). 
 
 
Practice Tip 
The carer and the person with dementia can access information about services and the service 
Guideline Evidence Reference 
The carer and the person with dementia need to be provided 
with advice on how agencies work together to provide a 
comprehensive service from diagnosis to the palliative phase 
Level IV (17) 
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system through The Commonwealth Respite and Carelink Centres by phoning Freecall 1800 052 
222*. For emergency respite support outside standard business hours, phone Freecall 1800 059 
059*  *Calls from mobile phones are charged at applicable rates 
 
6.2 Strategies for Carer Support 
6.2.1 Interventions to support the carer 
Caring for someone with dementia in the community can be physically and emotionally challenging 
and for some carers this may impact on their own physical and mental health.  There is evidence to 
suggest that the prevalence and incidence of depressive disorders is increased in caregivers of people 
living with dementia (45, 71).  A brief validated tool suitable for measuring carer strain is the Caregiver 
Strain Index (72). 
 
Studies have shown that the use of well designed psycho-educational or multi component 
interventions for caregivers of people living with dementia who live in the community can decrease 
caregiver burden and depression and increase subjective wellbeing among caregivers.  Limited 
evidence was available for ‘support only’ interventions (73). 
 
A systematic review by Parker et al (73) identified that effective interventions for carers are those 
which: 
• Provide opportunities within the intervention for the person living with dementia as well as the 
caregiver to be involved 
• Encourage active participation in educational interventions for caregivers 
• Offer individualised programs rather than group sessions 
• Provide information on an ongoing basis, with specific information about services and coaching 
regarding their new role 
• Offer support to the care recipient so as to reduce behavioural symptoms 
 
Obstacles to participation in interventions for carers can include lack of accessible transport and 
appropriate respite service provision and health professionals can assist by arranging appropriate 
transport and respite provision (17). 
 
Guideline Evidence Reference
The Caregiver Strain Index can measure the strain the carer is 
experiencing 
http://www.consultgerirn.org/uploads/File/Caregiver%20Strain%20Index.pdf  
Level III (72) 
Pyscho-educational and multi component interventions for carers reduce 
depression, burden and increase subjective wellbeing 
Level I (73) 
6.2.2 Impact of caring on sexual relationships 
Information regarding the impact of caring for a person who has dementia on sexual relationships is 
limited.  For the person with dementia sexual interests may be affected and this may manifest in 
decreased sexual interest or, conversely, hyper-sexuality.  Hyper-sexuality has been associated with 
frontal lobe dementia.  Partner carers, who provide hands on physical care as well as emotional care, 
may find their role changing from that of a sexual partner to a non-sexual carer role (17).  Health 
professionals’ awareness of the impact of dementia on the intimate and sexual relationship between 
the carer and the care recipient, and an ability to be open to discussion about this, is helpful. 
6.2.3 Respite care 
Although several well constructed research studies have been conducted on the impact of respite and 
centre based day care for the person who has dementia there is little evidence to support the benefits 
of these in terms of reduced carer burden although referral to respite and day care centres may 
enable the person who has dementia to stay in their own home for longer (16).  Despite the lack of 
evidence of the efficacy of these services the demand and continued use of respite services by people 
who have dementia and their carers suggests that they provide a valued contribution to the community 
life of this client group. 
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Care managers should ensure that people with dementia and their carers have access to a 
comprehensive range of respite/short break services.  This could include centre based day care, in-
home day and over-night respite, short term cottage respite, or overnight care in residential settings.  
Respite in a Residential Aged Care Facility (RACF) normally requires approval from an Aged Care 
Assessment Team (ACAT).  Health professionals should assist the carer in forward planning and be 
aware that assessment and approval by an ACAT should be planned in advance of the need for 
residential respite (22) wherever possible.  Flexible transport may be required if full access to these 
services is to occur.  Respite or short break care needs to be meaningful, tailored and in an 
environment that meets the needs of the person with dementia and their carer. 
 
Guideline Evidence Reference 
Referral to respite and centre based care may enable people with 
dementia to stay in their own homes for longer   
Level II (16) 
 
Practice Tips 
The ACAT assessment requires renewal annually and additional assessment is advised if the care 
needs of the person with dementia increase 
Contact The Commonwealth Respite and Carelink Centres on Freecall 1800 052 222* for local 
service information and additional respite needs. For emergency respite support outside standard 
business hours, phone Freecall 1800 059 059*  *Calls from mobile phones are charged at applicable rates 
For emergency respite in Australia contact the Commonwealth Respite and Carelink Centre on 
Freecall 1800 059 059*  * Calls from mobile phones are charged at applicable rates 
6.2.4 Abuse and neglect 
People living with dementia are at increased risk of emotional, financial, physical and sexual abuse or 
neglect.  Health professionals need to be aware of this possibility.  The new roles undertaken by the 
person with dementia and the care giver can place strains on their relationship and both parties can be 
vulnerable in a dysfunctional relationship (22).  Recognition of abuse is a complex and sensitive 
matter which requires skill and tact. 
 
Guideline Evidence Reference 
People living with dementia are at risk of abuse and health 
professionals should be aware of this possibility   
Level IV (22) 
 
Practice Tip 
Further information about neglect and abuse can be found at the Elder Abuse Prevention Unit (Qld) 
website (www.eapu.com.au ) or by phoning 1300 651 192 
In Queensland The Adult Guardian at the Qld Department of Justice can provide information and 
intervene if necessary.  The website address is: http://www.justice.qld.gov.au/17.htm 
6.2.5 Financial assistance 
People with dementia and their carers may find that their financial status is affected (17) and the 
benefits available should be discussed with the carer. 
 
Guideline Evidence Reference 
Health professionals need to be aware of the financial impact of 
caring for a person with dementia at home, discuss the benefits 
available and refer to appropriate organisations when necessary 
Level IV (17) 
 
Practice Tip 
Many carers are eligible for Carer Payment and/or Carer Allowance and Health Care Cards from 
Centrelink which also offers a financial advisory service.  The Centrelink website is: 
www.centrelink.gov.au  
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6.3 General Practitioner’s Post Diagnosis, Monitoring, Management and Care Phase Care Pathway 
  
Assessment of stage of 
dementia and functional 
level every 6 months 
• Global Deterioration Scale 
• Consider possible need for 
Driving Assessment. 
(Austroads provides 
information at 
www.austroads.com.au/aftd) 
• Decision making capacity  is 
to be assessed regularly 
• Be alert for issues between 
the carer and person who 
has dementia  
• Document assessment and 
record any actions  
 
Review current 
support and 
document any 
changes  
• Commencement 
or cessation of 
any services 
• Assessment from 
other Health 
professionals 
Interventions for cognitive symptoms and maintenance of cognitive function for the person who has 
dementia 
 
Assess and manage behavioural concerns  regularly 
Identify behaviours causing concerns regularly using the RMBPC.  Identify triggers, develop plan of care and 
review.  Provide helpline numbers 
Pain may be a source of agitation  
 
Support maintenance of function 
Promote and maintain independence with strategies that include scheduled toileting and prompted voiding  
Explore and explain the person’s abilities and limitations 
 
Assess and manage co-morbidities  
Regular assessment and review of any co-morbidities – including risk factors for falls - should be undertaken  
 
Abuse 
Monitor the person with dementia as may be at risk of abuse.  The Elder Abuse Prevention Unit can provide 
information. http://www.eapu.com.au/  
Interventions to support the carer 
Refer to agencies which can: 
• Assess carer strain using the Caregiver Strain Index (or obtain this from care manager or health 
professional) 
• Provide pyscho– social interventions which offer opportunities for both the person with dementia and 
the carer. 
• Provide active carer participation in individualised educational interventions  
• Provide ongoing information and support around the carer role 
Discuss 
• Financial benefits available to the carer and refer to the appropriate organisation e.g. Centrelink 
(http://www.centrelink.gov.au/internet/internet.nsf/individuals/carer_index.htm) 
• How agencies work together to provide a comprehensive service from diagnosis to the advanced phase 
• Referral to respite and centre based day care may delay admission to institutional care  
• Refer the person who has dementia and the carer to Alzheimer’s Australia or Alzheimers Association of 
Qld for information including help sheets available on line and by mail, and when needed, counselling 
and support 
• Provide carers with advice on how agencies work together to provide a comprehensive service from 
diagnosis to the advanced phase 
Pathway continues - General Practitioner’s Advanced Phase Care Pathway 
Pharmacological 
Interventions 
Refer to RACGP 
guidelines 
(www.racgp.org.au) 
Refer to NICE 
guidelines 
(www.nice.org.uk) 
Non-pharmacological 
interventions include 
• Reminiscence 
therapy 
• Behavioural 
Management 
• Music Therapy 
Refer and liaise 
with Community 
Health Services  
and/or 
community 
service providers 
on an ongoing 
basis to ensure 
appropriate 
support and 
communication 
between GP and 
other service 
providers and 
client/carer 
needs are met 
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6.4 Health Professional’s Post Diagnosis, Monitoring, Management and Care Phase Care Pathway 
  
Pathway continues – Health Professional’s Advanced Phase Care Pathway 
Review current support 
and document any 
changes  
• Commencement or 
cessation of any 
services 
• Assessment from other 
health professionals 
• Refer to General 
Practitioner / Specialist 
regarding any changes 
or concerns 
 
Coordination of 
services 
Carers should be given 
advice on how agencies 
work together to provide a 
comprehensive service 
from diagnosis to the 
palliative phase  
Supporting the carer - Interventions for carer support 
Complete Carer Strain Index 
Respite care 
Referral to respite and centre based day care centres may enable people to stay in their own homes for longer Practice Tip: 
The Commonwealth Respite and Carelink Centres (Freecall 1800 052222*) can provide relevant information.  For 
emergency respite support outside standard business hours Freecall 1800 059 059*. Call from mobile phones charged at 
applicable rates. 
Financial assistance 
Health professionals should be aware of the financial impact of caring, discuss benefits available and refer to appropriate 
organisations.  Practice Tip: Centrelink (http://www.centrelink.gov.au/internet/internet.nsf/individuals/carer_index.htm ) 
provides information about Carer Payment and Carer Allowance. 
Impact of caring on the relationship between the carer and person who has dementia 
• Pyscho – social interventions with educational and multi component aspects can be of assistance. These can assist in 
reducing depression and burden and increasing subjective wellbeing.  Offer interventions which provide opportunities for 
both the person with dementia and the carer, and provide ongoing information and support around the carer role. 
• Refer the person who has dementia and the carer to Alzheimer’s Australia for information sheets and to dementia aware 
services that can offer support groups, counselling and other information as needed 
Abuse 
Monitor the person with dementia as may be at risk of abuse.  The Elder Abuse Prevention Unit can provide information.  
http://www.eapu.com.au/  
 
Supporting the person with dementia 
• Maintenance of function e.g. ADL support, prompted voiding 
• Discuss legal issues 
• Discuss driving 
• Observe physical environment and arrange modifications if these are required 
 
Assess and manage co-morbidities of the person with dementia 
Regular assessment and review of any co-morbidities, including risk factors for falls, 
should be undertaken.    
 
Management of behaviours 
Assess and manage behavioural concerns for the person with dementia regularly 
(RMBPC)
Non-pharmacological 
interventions include 
• Reminiscence therapy 
• Behavioural Management 
• Music Therapy 
36 
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6.5 Care Worker’s Post Diagnosis, Monitoring, Management And Care Phase Care Pathway 
Supporting the carer 
Interventions for carer 
support 
Note any concerns of carer and 
refer these to the care manager. 
This may include discussions 
that the carer has had with the 
care worker about the following: 
 
Respite and centre based day 
care  
Which may enable people to 
stay in their own homes for 
longer 
 
Financial assistance 
Which may assist the carer to 
cope with the financial impact of 
caring 
 
Caring Relationship  
Which may face difficulties as an 
outcome of the impact of caring  
 
Interventions for the person 
with dementia 
Follow the care plan and ensure 
maintenance of function by 
promoting and maintaining 
independence.  Promote 
scheduled toileting and 
prompted voiding  
 
Report any behaviour 
changes to the care manager 
and follow the strategies 
outlined in the behaviour care 
plan  
 
Report any risk factors for 
falls  
 
Report any signs or 
symptoms of pain. 
This  may be a source of 
agitation  
 
It is important to discuss any 
issues concerning changes in 
the person with dementia with 
the care manager as the person 
may also experience other 
treatable difficulties such as 
depression or delirium. 
Supporting the person living 
with dementia 
Pathway continues – Care Worker’s Advanced Phase Care Pathway 
Care workers are 
to contribute to 
care plan 
development and 
review 
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7 Advanced Phase 
In this phase there is evidence of severe cognitive decline which is irreversible.  The individual 
prognosis is very difficult to predict because the disease is life-limiting and progressive and a palliative 
approach is recommended.  This stage of dementia may be referred to as advanced dementia, late 
stage, or severe dementia.  In this phase the person who has dementia is severely disabled and 
needs total care.  The Functional Assessment Staging Tool (FAST) (74) has been used to identify 
people with dementia who are in the late-stage of dementia. A FAST rating at, or beyond, Stage 7A 
has been used as an indicator of a prognosis of six months or less if the person also exhibits one or 
more specific dementia-related co-morbidities (aspiration, upper urinary tract infection, sepsis, multiple 
Stage 3-4 ulcers, persistent fever, weight loss >10% within six months) (75).   
 
In this phase health professionals are responsible for: 
 
 
Characteristics of the advanced phase of dementia can include the person (10) :  
 
• Being unable to remember - for even a few minutes - that they have had, for example, a meal 
• Experiencing loss of ability to understand or use speech 
• Being incontinent (of both urine and faeces) 
• Experiencing swallowing difficulties 
• Having no recognition of friends and family 
• Requiring help with eating, washing, bathing, or dressing 
• Being unable to recognise everyday objects 
• Being disturbed at night 
• Being restless, perhaps looking for a long dead relative 
• Being aggressive, especially when feeling threatened or closed in 
• Having difficulty walking, eventually perhaps becoming confined to a wheelchair  
• Suffering from immobility or becoming bedridden 
• Having uncontrolled movements 
 
Guideline Evidence Reference 
The Functional Assessment Staging Tool (FAST) is a useful tool 
for detailed staging in advanced dementia and can be found at the 
following website: 
(http://ec-online.net/Knowledge/articles/alzstages.html ) 
Level IV (8) 
 
• Providing information and support regarding the advanced phase of dementia 
• Ensuring that the person with dementia and their carers have access to appropriate services 
that provide a palliative approach 
• Continued follow up and evaluation of all symptoms including any treatable reasons for 
confusion 
• Reviewing goals of care to promote comfort , quality of life and dignity 
• Providing management strategies for maximising comfort  
• Liaising with carers regarding advance health directives particularly with regard to nutrition, 
hydration, symptom management and place of care 
• Providing information and support to the carer regarding the need for respite and/or institutional 
care as appropriate 
• Providing support for carers who may be experiencing anticipatory grief 
• Providing support for carers in bereavement 
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7.1 Management Strategies for Persons With Dementia 
7.1.1 A palliative approach 
Adopting a palliative approach to care benefits the person who has dementia and their family carers 
(76).  A palliative approach supports the dignity of the person who has dementia and promotes the 
concept of death in the place of choice for the person who is ill.  Feelings of grief and loss need to be 
anticipated from the time of diagnosis to death and grief and bereavement counselling should be 
available to carers.  A conference with the General Practitioner, other health professionals and the 
family can provide an opportunity to discuss end-of-life issues (76).  The use of advance care planning 
should help the person with dementia to retain some control over their care (17). 
 
Guideline Evidence Reference 
Family conferences attended by the GP provide an opportunity for 
discussing end-of-life issues 
Level III (76) 
Primary care teams need to ensure that the palliative care needs of 
people with dementia who are close to death are assessed and 
that the information is communicated within the team and others  
Level IV (17) 
 
Practice Tip 
The carer may wish to contact the Palliative Care Information and Support Line by phoning Freecall 
1800 772 273*  *Calls from mobile phones are charged at applicable rates 
Further information about Palliative Care Guidelines can be found on the Caresearch 
(www.caresearch.com.au ) and Palliative Care Australia (www.palliativecare.org.au ) websites 
 
7.1.2 Hydration and nutrition 
People with dementia need to be encouraged to eat and drink by mouth for as long as possible (17) . 
Artificial (tube) feeding is not recommended for people with severe dementia, although it may be used 
in circumstances where dysphagia is considered to be a transient phenomenon rather than a 
manifestation of the severity of the disease process.  Evidence suggests that tube feeding does not 
prolong life or reduce suffering (24). 
 
Guideline Evidence Reference 
Artificial (tube) feeding is not recommended for people with 
dementia 
Level I (24) 
 
Practice Tip 
People of different CALD backgrounds may be quite reticent to confront and discuss the fact that 
the patient is not going to recover and in these circumstances may request that artificial feeding and 
other interventions continue as a sign that everything is being done that is possible to support the 
person who has dementia 
7.1.3 Fever and infection 
Where the person with severe dementia has a fever, especially in the terminal stages, a clinical 
assessment is required to determine whether the fever is from a reversible cause that should be 
treated.  Simple analgesics, antipyretics and mechanical means of cooling can provide comfort. 
Prescription of antibiotics for the person who has dementia in the advanced phase may be considered 
for palliative symptom relief (76). 
 
Guideline Evidence Reference 
Antibiotics for fever management in the advanced phase of 
dementia can be considered as a palliative measure  
Level III (76) 
7.1.4 Symptom management 
If people with dementia have unexplained changes in behaviour, the care manager should assess 
whether the person with dementia is experiencing pain.  The possibility that the distress experienced 
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by the person with dementia might have other causes also needs to be considered.  Health 
professionals caring for clients with dementia need to be knowledgeable about pain assessment and 
management in this population so that physical and emotional well-being is promoted (76, 77).  During 
this phase, the person with dementia may be unable to verbally express pain, and an observational 
pain assessment tool may be used. The Abbey Pain Scale (78) is a brief tool for use in the residential 
aged care setting which incorporates the perception of nurses as an indicator of the experience of 
pain.  Health professionals should be aware that the treatment of pain needs to involve both 
pharmacological and non-pharmacological means.  Non-pharmacological therapies should reflect the 
history and preferences of the person who has dementia (17). 
 
Guideline Evidence Reference 
Health professionals caring for clients with dementia need to 
be knowledgeable about pain assessment and management 
in this population to promote physical and emotional well-
being  
Level III (76) 
The Abbey Pain Scale is a brief tool for use in measuring the 
pain levels experienced by the person who has dementia in 
this phase 
Level III (78) 
7.1.5 Admission to Residential Care  
Health professionals’ awareness that carer stress, the functional dependency of the person who has 
dementia, behaviours of concern and incontinence are factors that may lead the carer to consider 
alternatives to maintaining the caring role is important (16).  Admission into a permanent residential 
aged care facility (RACF) requires approval and identification of care needs from an Aged Care 
Assessment Team (ACAT). Health professionals need to assist the carer in forward planning and be 
aware that assessment and approval by an ACAT needs to be planned in advance of the need for 
residential care (22).  In Australia the assessment is time limited and requires annual review with 
additional assessment recommended if care needs increase from a low level to a high level. 
 
Guideline Evidence Reference 
Where care in a setting other than the home is required, staff  
awareness of the wishes of the person who has dementia with 
regard to life sustaining treatments allows for their personal 
choices to be honoured 
Level IV (76) 
The carer is likely to benefit from the assistance of health 
professionals in planning for residential care if it is anticipated that 
this may be required 
Level IV (22) 
 
7.2 Strategies for Carer Support 
7.2.1 Decision making/advance directives 
While decisions regarding advance directives may have been discussed at diagnosis and throughout 
the progression of dementia, during the advanced phase it is important for health professionals to 
review these decisions with carers.  
 
Guideline Evidence Reference 
Advance care options should be discussed again with carers  Level I (16) 
 
7.2.2 Grief and loss 
Both the person who has dementia and the carer experience progressive losses over an extended 
period as death approaches (46).  The process of bereavement includes not only the death but also 
psychological issues such as anticipation of loss, adjustment to circumstances and experiences of 
grief  (9).  Health professionals need to maintain an awareness of these issues and consider referral to 
a practitioner or funded service with expertise in addressing these issues (22). 
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Guideline Evidence Reference 
Health professionals who are aware of the psychological impact of 
caring for someone in the advanced stage can assist by 
assessing the need of the carer for referral to a specialist 
practitioner 
Level IV (22) 
 
Practice Tip 
Counselling for carers may be available through the following funded resources 
The National Carer Counselling Program                                             Freecall:1800 242 636* 
The National Dementia Helpline                                                           Freecall:1800 100 500* 
The Palliative Care Information and Support Line                                Freecall:1800 772 222* 
*Calls from mobile phones are charged at applicable rates 
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7.3 General Practitioner’s Advanced Phase Care Pathway 
 
GP has assessed the 
person with dementia as at 
Stage 7A or greater on the 
Functional Assessment 
Staging Tool. This may 
mean that vocabulary 
becomes limited, eventually 
declining to single words, 
and the person with 
dementia loses ability to 
walk and sit. They may also 
be unable to smile 
 
Health 
professional or GP 
to schedule a case 
conference which 
includes relevant 
Health 
professionals to 
discuss with carer 
implications for 
this stage of 
dementia  
Symptom management 
• Pain – valid and reliable pain assessment 
tools  need to be used. NOTE: Pain may be a 
source of agitation  
• Infection – consider antibiotics as a palliative 
measure  
Hydration and nutrition 
Encourage the person with dementia to eat and 
drink by mouth as long as able. Artificial tube 
feeding is not recommended  
Assessment and 
management of the 
person with dementia 
to evaluate ongoing 
care needs in the 
community 
Assessment and 
management of  
carer needs 
Decision making 
Advance care options need to be discussed with 
carers  
Care options 
Health professionals need to assist carers in 
planning for residential care if it is anticipated that 
this may be required  
Referral to a specialist palliative care service is 
appropriate 
Grief  
General Practitioners and other health 
professionals need to be aware of the 
psychological impact of caring for someone at the 
advanced phase and assess the need for referral 
to a specialist practitioner such as a social worker 
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7.4 Health Professional’s Advanced Phase Care Pathway 
  
GP has assessed the 
person with dementia as at 
Stage 7A or greater on the 
Functional Assessment 
Staging Tool. This may 
mean that vocabulary 
becomes limited, eventually 
declining to single words, 
and the person with 
dementia loses ability to 
walk and sit. They may also 
be unable to smile 
 
Health 
professional or GP 
to schedule a case 
conference which 
includes relevant 
health 
professionals to 
discuss with carer 
implications for 
this stage of 
dementia  
Symptom management 
• Pain – valid and reliable pain assessment 
tools  need to be used. NOTE: Pain may be a 
source of agitation  
• Infection – consider antibiotics as a palliative 
measure  
Hydration and nutrition 
Encourage the person with dementia to eat and 
drink by mouth as long as able. Artificial tube 
feeding is not recommended. 
Assessment and 
management of the 
person with dementia 
to evaluate ongoing 
care needs in the 
community 
Assessment and 
management of  
carer needs 
Decision making 
Advance care options need to be discussed with 
carers  
Care options 
Health professionals need to assist carers in 
planning for residential care if it is anticipated that 
this may be required  
Referral to a specialist palliative care service is 
appropriate 
Grief 
General Practitioners and other health 
professionals need to be aware of the 
psychological impact of caring for someone at the 
advanced phase and assess the need for referral 
to a specialist practitioner such as a social worker 
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7.5 Care Worker’s Advanced Phase Care Pathway 
 
Supporting the carer 
Interventions for carer support 
 
Refer carer changes or concerns to 
the care manager.  This includes 
discussions the carer may have with 
respect to: 
 
Respite care 
Referral to respite and centre based 
day care centres may enable people to 
stay in their own homes for longer 
 
Tensions in the relationship  
These may have arisen or become 
more difficult due to the impact of 
caring on the relationship between the 
carer and the person with dementia.   
 
Grief and bereavement 
General Practitioner and other health 
professionals should be aware of 
psychological impact of caring for 
someone at the advanced phase and 
assess the need for referral to a 
specialist practitioner or appropriately 
funded service 
Interventions for the person with 
dementia 
 
Follow the care plan and ensure: 
 
Maintenance of comfort 
Monitor for any signs of pain or 
discomfort  
 
Hydration and nutrition 
Encourage to eat and drink by mouth 
as long as able. Artificial tube feeding is 
not recommended  
 
Symptom management 
Infection –  antibiotics may be 
prescribed as a palliative measure  
NOTE: Pain may be a source of 
agitation 
 
Report any changes or concerns to 
the care manager 
 
Supporting the person with dementia 
Care worker to 
contribute to care 
plan development 
and review 
 
Health professional, 
care manager or GP to 
schedule a case 
conference which 
includes relevant 
health professionals to 
discuss with carer the 
implications for this 
stage of dementia.  
Input from the care 
worker will be of 
assistance 
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Appendix 1 The AGREE Instrument 
 
The AGREE Instrument considers 6 different aspects, or domains, of guideline development. 
There are 23 questions. Domains include: 
 
1. Scope and purpose  
2. Stakeholder involvement  
3. Rigour of development  
4. Clarity and presentation  
5. Applicability  
6. Editorial Independence  
 
RESPONSE SCALE 
• Each item is rated on a 4 point scale ranging from (4) ‘Strongly Agree’ to (1) ‘Strongly 
Disagree’, with 2 midpoints – (3) ‘Agree’ and (2) ‘Disagree’. 
• If the reviewer is confident that the criterion has been fully met then they should answer 
‘Strongly Agree’ 
• If the reviewer is confident that the criterion has not been fully met then they should 
answer ‘Strongly Disagree’ 
• If the reviewer is unsure that a criterion has been fulfilled, for example because the 
information is unclear or because only some of the recommendations fulfil the criterion, 
then the reviewer should answer ‘Agree’ or ‘Disagree’ depending on the extent to which 
the reviewer thinks the issue has been addressed. 
 
RATING GUIDELINES 
 
Domain scores can be calculated by summing up all the scores of the individual items in a 
domain and by standardising the total as a percentage of the maximum possible score for that 
domain. This allows an aggregate score between reviewers. However, no threshold marks 
have been set for inclusion or exclusion of items. 
The overall assessment contains a series of options: 
1. Strongly Recommend 
2. Recommend (with provisos or alterations) 
3. Would not Recommend  
4. Unsure 
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Guideline name:DateAuthor 
 Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
SCOPE AND PURPOSE      
1. The overall objective(s) of the guideline should be specifically described.      
2. The clinical question(s) covered by the guideline should be specifically 
described.  
    
3. The patients to whom the guideline is meant to apply should be specifically 
described.  
    
STAKEHOLDER INVOLVEMENT      
4. The guideline development group should include individuals from all the 
relevant professional groups.  
    
5. The patients’ views and preferences should be sought.      
RIGOUR OF DEVELOPMENT      
6. Systematic methods should be used to search for evidence.      
7. The criteria for selecting the evidence should be clearly described.      
8. The methods used for formulating the recommendations should be clearly 
described.  
    
9. The health benefits, side effects and risks should be considered in 
formulating the recommendations.  
    
10. There should be an explicit link between the recommendations and the 
supporting evidence.  
    
11. The guideline should be externally reviewed by experts prior to 
publication.  
    
12. A procedure for updating the guideline should be provided.      
CLARITY AND PRESENTATION      
13. The recommendations should be specific and unambiguous.      
14. The different options for diagnosis and/or treatment of the condition 
should be clearly presented.  
    
15. Key recommendations should be easily identifiable.      
APPLICABILITY      
16. The target users of the guideline should be clearly defined.      
17. The potential organisational barriers in applying the recommendations 
should be discussed.  
    
18. The potential cost implications of applying the recommendations should 
be considered.  
    
19. The guideline should be supported with tools for application.      
20. The guideline should present key review criteria for monitoring and audit 
purposes  
    
21. The guideline should be piloted among end users.      
EDITORIAL INDEPENDENCE      
22. The guideline should be editorially independent from the funding body.      
23. Conflicts of interest of guideline development members should be 
recorded.  
    
 
OVERALL ASSESSMENT 
Would you recommend these guidelines for use in practice? 
 
Strongly 
Recommend 
Recommend (with 
provisos or alterations) 
Would not 
recommend 
Unsure 
 
Comments: 
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Appendix 2 Guidelines Included 
 
Guideline title Organisation Year Agree 
rating
Screening for Delirium, Dementia and 
Depression in Older Adults 
Registered Nurses Association 
of Ontario 
2003 92% 
Care giving Strategies for Older 
Adults with Delirium, Dementia and 
Depression 
Registered Nurses Association 
of Ontario 
2004 89% 
Management of patients with 
dementia 
Scottish Intercollegiate 
Guidelines Network 
2006 88% 
Practice parameter: Early detection of 
dementia: Mild cognitive impairment 
(an evidence-based review) 
Report of the Quality Standards 
Subcommittee of the American 
Academy of Neurology 
 
2001 85% 
Screening for Dementia United States Preventive 
Services Task Force 
(USPSTF), 
2003 84% 
Screening for cognitive impairment 
and dementia in the elderly 
Canadian Task Force on 
Preventative Health 
2001 81% 
The recognition, assessment and 
management of dementing disorders:  
Canadian Consensus 
Conference on Dementia 
1999 80% 
The primary care management of 
dementia 
North of England Evidence 
Based Guideline Development 
Project 
1998 80% 
Guidelines for Alzheimer’s Disease 
Management 
California Working Group on 
Guidelines for Alzheimer's 
Disease Management 
2002 79% 
Practice Guidelines for the Treatment 
of Patients with Alzheimer's Disease 
and Other Dementias of Late Life 
American Psychiatric 
Association 
1997 77% 
Practice parameter: Management of 
dementia (an evidence based review): 
Report of the Quality Standards 
Subcommittee of the American 
Academy of Neurology 
2001 75% 
Care of Patients with Dementia in 
General Practice Guidelines 
New South Wales Department 
of Health 
2003 74% 
Practice parameter: Diagnosis of 
dementia (an evidence based review) 
Report of the Quality Standards 
Subcommittee of the American 
Academy of Neurology 
2001 70% 
Practice parameter: Risk of driving 
and Alzheimer's disease (an 
evidence-based review).  
Report of the Quality Standards 
Subcommittee of the American 
Academy of Neurology 
2000 70% 
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Appendix 3 Guidelines Excluded 
 
Guideline title Organisation Year Agree
rating
Dementia Guidelines for Early 
Detection, Diagnosis and Management 
of Dementia 
American Academy of 
Neurology's 
2003 68% 
Non-pharmacologic management of 
agitated behaviours in persons with 
Alzheimer's disease and other chronic 
dementing illnesses 
University of Iowa 
Gerontological Nursing 
Interventions Research Centre 
2004 67% 
Interventions in the management of 
behavioural and psychological aspects 
of dementia 
Scottish Intercollegiate 
Guidelines Network 
1998 67% 
Clinical Practice Guidelines - Dementia Ministry of Health Singapore 2001 59% 
Treatment of Agitation in Older 
Persons with Dementia 
The Expert Consensus 
Guideline Series 
1998 57% 
Guidelines for Managing Alzheimer's 
Disease Part I Assessment, Part II. 
Treatment 
American Family Physician 2002 57% 
Guidelines for the Support and 
Management of People with Dementia 
Ministry of Health New Zealand 1997 51% 
Managing Dementia Exeter Primary Care Group 2000 33% 
Diagnosis and treatment of Alzheimer 
disease and related disorders.  
Consensus statement of the 
American Association for 
Geriatric Psychiatry, the 
Alzheimer's Association, and 
the American Geriatrics Society 
1997 26% 
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Appendix 4 Levels of Evidence 
 
Adapted from types of studies used in this protocol   
 
Evidence Level Study Design Protocol 
Level 1 Systematic Review Systematic location, appraisal and 
synthesis of evidence from scientific 
studies. 
Level 1 Experimental Studies 
Randomised Controlled 
Trial 
Subjects are randomly allocated to 
groups either for the 
intervention/treatment being studied or 
control/placebo (using a random 
mechanism, such as coin toss, random 
number table, or computer-generated 
random numbers) and the outcomes 
compared. 
Level 2 Pseudo-randomised 
controlled trial 
Subjects are allocated to groups for 
intervention/treatment or 
control/placebo using non-random 
method (such as alternate allocation, 
allocation by days of the week, or odd-
even study numbers) and the outcomes 
are compared. 
Level 2 Clustered randomised 
trial 
Subjects are randomised to intervention 
or control in groups (families, 
communities, hospitals). 
Level 3 Concurrent control or 
cohort 
Outcomes are compared for a group 
receiving the treatment/intervention 
being studied, concurrently with control 
subjects receiving the comparison 
treatment/intervention (e.g. usual or no 
care). 
Level 3 Case-control Subjects with the outcome or disease 
and an appropriate group of controls 
without the outcome or disease are 
selected and information is obtained 
about the previous exposure to the 
treatment/intervention or other factor 
being studied. 
Level 3 Historical control Outcomes for a prospectively collected 
group of subjects exposed to the new 
treatment/intervention are compared 
with either a previously published 
series or previously treated subjects at 
the same institutions. 
Level 3 Interrupted time series Trends in the outcome or disease are 
compared over multiple time points 
before and after the introduction of the 
treatment/intervention or other factor 
being studied. 
Level 3 Case series A single group of subjects are exposed 
to the treatment/intervention. 
 
Level 3  Post-test Only outcomes after the intervention 
are recorded in the case-series, so no 
comparisons can be made. 
Level 3 Pre-test/post-test Outcomes are measured in subjects 
before and after exposure to the 
treatment/intervention for comparison 
(also called a ‘before-and-after’ study). 
Level 4 Expert opinion without 
critical appraisal or 
based on consensus 
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Appendix 5 Alzheimer’s Association Referral Form 
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